THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
182,844,612
Share change
-12,942,215
Total reported value
$189,844,871
Put/Call ratio
119%
Price per share
$1.06
Number of holders
135
Value change
-$31,618,067
Number of buys
45
Number of sells
85

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2020

As of 31 Mar 2020, THERAPEUTICSMD INC - COM (TXMD) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 182,844,612 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Bank of New York Mellon Corp, Rubric Capital Management LP, FRANKLIN RESOURCES INC, C WorldWide Group Holding A/S, and STATE STREET CORP. This page lists 135 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.